Andera Partners | WebDisclosure

Basculer en Français

8301	Companies
115073	Keywords
55420	Articles
62512	Press releases

Home
Companies
Andera Partners

BRIEF

published on 07/25/2024 at 09:35, 3 months 27 days ago

TRiCares Secures $50 Million Series D Financing for Clinical Advancements

Clinical Trials Andera Partners TRiCares Series D Financing Heart Valve System
PRESS RELEASE

published on 07/25/2024 at 09:30, 3 months 27 days ago

Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upcoming Clinical Milestones
Andera Partners' portfolio company TRiCares secures $50 million in Series D Financing to support upcoming clinical milestones for its tricuspid heart valve replacement system, Topaz

Clinical Milestones Andera Partners TRiCares Series D Financing Topaz
BRIEF

published on 07/15/2024 at 09:35, 4 months 6 days ago

Amolyt Pharma, une société de portefeuille d'Andera Partners, acquise par AstraZeneca

Acquisition Produits Biopharmaceutiques AstraZeneca Amolyt Pharma Maladies Rares
BRIEF

published on 07/15/2024 at 09:35, 4 months 6 days ago

Amolyt Pharma, a Portfolio Company of Andera Partners, Acquired by AstraZeneca

Acquisition Biopharmaceuticals AstraZeneca Amolyt Pharma Rare Diseases
PRESS RELEASE

published on 07/15/2024 at 09:30, 4 months 6 days ago

Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca
Andera Partners' portfolio company Amolyt Pharma has been acquired by AstraZeneca for $1.05 billion, enhancing AstraZeneca's Rare Disease late-stage pipeline and bone metabolism franchise

Acquisition Biopharmaceutical AstraZeneca Amolyt Pharma Andera Partners
BRIEF

published on 07/09/2024 at 08:15, 4 months 12 days ago

Andera Partners codirige la série A de 63 millions d'euros pour la biotechnologie SciRhom

Produits Biopharmaceutiques Maladies Auto-immunes Financement De Série A Partenaires Andera SciRhom
BRIEF

published on 07/09/2024 at 08:15, 4 months 12 days ago

Andera Partners Co-Leads €63 Million Series A for Biotech SciRhom

Series A Financing Biopharmaceuticals Andera Partners Autoimmune Disorders SciRhom
PRESS RELEASE

published on 07/09/2024 at 08:10, 4 months 12 days ago

Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom
Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom to advance novel iRhom2 antibody therapy towards clinical proof-of-concept

Andera Partners SciRhom Autoimmune Biotech Series A Round IRhom2 Antibody
BRIEF

published on 03/14/2024 at 11:15, 8 months 7 days ago

Tubulis, la société de portefeuille d'Andera Partners, obtient un financement de série B2 de 128 millions d'euros

Essais Cliniques Tubulis Partenaires Andera Financement De Série B2 Développement ADC
BRIEF

published on 03/14/2024 at 11:15, 8 months 7 days ago

Andera Partners’ Portfolio Company Tubulis Secures €128 Million in Series B2 Financing

Clinical Trials Andera Partners Tubulis Series B2 Financing ADC Development

Accesswire

Published on 11/21/2024 at 17:35, 33 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 38 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 38 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 7 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 8 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 17:58, 10 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 16 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 16 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 17 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 17:51, 17 minutes ago

2CRSi SA: 2CRSi fournit à Exaion, filiale du groupe EDF, des serveurs à hautes performances en immersion en Amérique du Nord

Les Echos

Published on 11/21/2024 at 06:58, 11 hours 10 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 11 hours 10 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 11 hours 10 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 22 hours 1 minute ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 22 hours 48 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE